Nearly 20 companies have been named in lawsuits over decongestants that a U.S. Food and Drug Administration panel found didn’t work at all; some are saying they shouldn’t be sued.
Following a meeting on Sept. 11 and Sept. 12, an FDA committee found oral decongestants containing phenylephrine, purchased over the counter for colds and flus, were not effective. About 30 class actions followed, most naming the Procter & Gamble Co. and Johnson & Johnson. But dozens of other companies with big names have been sued, many of which sell store brand decongestants, such as Walgreens, Walmart, Target, CVS and Rite Aid.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
